Back
Charles River Laboratories International Stock Predictions

The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.
Sell
49
CRL
Charles River Laboratories International
Last Price:
$144.67
Seasonality Move:
4.04%
7 Day Trial
ALL ACCESS PASS
$
7

Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.Charles River Laboratories International Stock Forecast
-
Over the next 52 weeks, Charles River Laboratories International has on average historically risen by 10.3% based on the past 24 years of stock performance.
-
Charles River Laboratories International has risen higher in 17 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.83%
-
Is Charles River Laboratories International Stock Undervalued?The current Charles River Laboratories International [CRL] share price is $144.70. The Score for CRL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
CRL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Charles River Laboratories International Stock Go Up Next Year?
-
Over the next 52 weeks, Charles River Laboratories International has on average historically risen by 10.3% based on the past 24 years of stock performance.
Charles River Laboratories International Stock Rating
Sell
49
Charles River Laboratories International (CRL)
is a Sell
Is Charles River Laboratories International overpriced?
-
Charles River Laboratories International has risen higher in 17 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.83%
Charles River Laboratories International Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
criver.com
52-Week Data
52-Week High:
254.15
52-Week Low:
91.86
Prediction Charts
Market Cap:
7.1B
Price in USD:
144.70
Volume:
938K
Beta:
0.99
Technical Analysis
SMA50:
129.86
SMA100:
148.07
SMA200:
171.23
52-Wk Change:
-34.71%
Stock Predictions
-
Is Charles River Laboratories International stock public?Yes, Charles River Laboratories International is a publicly traded company.
-
What is the Charles River Laboratories International stock quote today?The Charles River Laboratories International stock price is 144.70 USD today.
-
How to buy Charles River Laboratories International stock online?You can buy Charles River Laboratories International shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-19 | 138.00 | 141.38 | 141.50 | 137.72 |
May-20 | 141.37 | 143.53 | 143.82 | 140.34 |
May-21 | 141.39 | 134.98 | 141.71 | 134.86 |
May-22 | 133.79 | 135.60 | 136.26 | 133.34 |
May-23 | 134.21 | 136.73 | 137.00 | 133.85 |
May-27 | 140.11 | 138.65 | 140.65 | 138.61 |
May-28 | 137.96 | 136.25 | 138.89 | 136.12 |
May-29 | 138.22 | 137.70 | 138.61 | 135.78 |
May-30 | 136.42 | 135.63 | 136.94 | 134.08 |
Jun-2 | 134.80 | 135.04 | 135.44 | 132.58 |
Jun-3 | 135.23 | 138.49 | 139.73 | 132.65 |
Jun-4 | 138.90 | 143.22 | 145.93 | 138.81 |
Jun-5 | 143.36 | 141.20 | 144.88 | 140.78 |
Jun-6 | 143.12 | 144.70 | 145.65 | 143.12 |
Charles River Laboratories International Earnings
Charles River Laboratories International Earnings Report: Per Share Charles River Laboratories International Earnings Q1 Q2 Q3 and Q4 last year and next year.
Charles River Laboratories International Forecast Revenue Growth
Charles River Laboratories International Stock Analysis: Historical quarterly revenues per share for Charles River Laboratories International and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.56 per share, and an increase next year of $0.70 per share.
* Charles River Laboratories International stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.